2018 Korean Heart Rhythm Society Guidelines for The Rate Control of Atrial Fibrillation.
10.3904/kjm.2018.93.2.133
- Author:
Woo Hyun LIM
1
;
Eue Keun CHOI
;
Boyoung JOUNG
;
Kee Joon CHOI
Author Information
1. Division of Cardiology, Department of Internal Medicine, Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea.
- Publication Type:Practice Guideline ; Review
- Keywords:
Atrial fibrillation;
Heart rate;
Practice guideline
- MeSH:
Asian Continental Ancestry Group;
Atrial Fibrillation*;
Calcium Channel Blockers;
Consensus;
Digoxin;
Dyspnea;
Heart Rate;
Heart*;
Humans
- From:Korean Journal of Medicine
2018;93(2):133-139
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Atrial fibrillation (AF) is characterized by irregular and relatively rapid heart rate, which occasionally causes symptoms such as palpitations, dyspnea, or reduced exercise capacity. Controlling the ventricular rate is a mainstay for the symptom management of patients with AF. Rate control can be achieved with beta-blockers, non-dihydropyridine calcium channel blockers, digoxin, or combination therapy. Rhythm control is an option for patients in whom appropriate rate control cannot be achieved or who have persistent symptoms despite rate control. The choices of drug and target heart rate are usually specified by international guidelines for AF management. However, pivotal trials included in those guidelines enrolled only a small number of Asian subjects, which limit application of those guidelines to a Korean population. The Korean Heart Rhythm Society organized the Korean AF Management Guideline Committee and analyzed all available studies regarding management of AF including studies with Korean patients. Then, expert consensus or guidelines for optimal management in Korean patients with AF were achieved after systematic review with intensive discussion. This article provides general principles for rate control therapy in Korean patients with AF.
